SUBSCRIBE
SUBSCRIBE
News   Business

Genzyme Corporation 3Q Net Falls 87% Amid Drug-Making Woes

October 21, 2009 | 
1 min read
Bookmark and Share

Oct. 21 (Bloomberg) -- Genzyme Corp., said profit fell 87 percent as a plant closure restricted drug supplies, and the company lowered its full-year earnings forecast.
Earnings
MORE ON THIS TOPIC
Illustration showing line of people leaving, standing on top of hand pointing their way out
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
 · 
1 min read
 · 
Angela Gabriel
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac
The Westin St. Francis in San Francisco, home of the J.P. Morgan Healthcare Conference.
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
 · 
2 min read
 · 
Annalee Armstrong
Businessman facing gap obstacle to achieve his goal. Obstacle and overcome concept vector illustration
Earnings
After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral
February 26, 2026
 · 
5 min read
 · 
Annalee Armstrong